CFO  News Hubb
Advertisement
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact
No Result
View All Result
CFO  News Hubb
No Result
View All Result
Home Financial Advisor

In Defense of Pharmacy Benefit Managers

by admin
July 12, 2022
in Financial Advisor


Washington is a town not known for bipartisan agreement. But its swarms of drug-company lobbyists appear to have united both parties in opposition to pharmacy benefit managers. PBMs are taking the blame for high drug prices.

PBMs manage prescription-drug benefits for payers like health insurers, plan sponsors and large employers. Their job is to keep costs down and manage patient care. Democrats don’t like this arrangement because they want the federal government to control prices. Republican anger is harder to understand. It may stem from a lack of understanding of the value PBMs provide. Plan sponsors work with PBMs, despite having no obligation to do so, because they can reduce a plan’s drug costs by half. These savings translate to lower health-insurance premiums and better drug utilization. When patients stay on their drugs and out of the hospital it saves patients and plans buckets of money. The net value of pharmacy benefit management exceeds $145 billion annually.



Source link

Previous Post

GOP Gambit Could Help U.S. Energy Producers Build Back Better

Next Post

The Umpire Strikes Back – WSJ

TRENDING

Financial Advisor

China, Russia and the West’s Crisis of Disbelief

August 7, 2022
Financial Advisor

What Germans Know About Nuclear Power

August 7, 2022
Financial Advisor

Democrats Vote to Raise Drug Prices

August 7, 2022
Financial Advisor

Donald Trump’s Nominees and the Senate

August 7, 2022
Financial Advisor

Joe Manchin’s Legacy Now Depends on Permitting Reform

August 7, 2022

© 2022 CFO News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

Newsletter Sign Up

No Result
View All Result
  • Home
  • CFO News
  • Financial Advisor
  • Financial Planning
  • Markets News
  • Economics
  • Contact

© 2022 CFO News Hubb All rights reserved.